• Product NameTasisulam
• Brief DescriptionInhibitors
• Purification99.97%
• Biological ActivityTasisulam is an antitumor agent and an apoptosis inducer via the intrinsic pathway. Phase 3
• Target NameCaspase activator
• CAS No. 519055-62-0
• Calculated MW 415.11
• Formulation C11H6BrCl2NO3S2
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Cancer
  SMILES:ClC1=CC(Cl)=C(C=C1)C(=O)NS(=O)(=O)C1=CC=C(Br)S1 |c:4,6,t:1,15,17|
  Pathways:Apoptosis; Proteases/Proteasome
  Receptor:Caspase
  Boling pt:
  Melting pt:
  Solubility:DMSO:83 mg/mL (199.94 mM)Ethanol:83 mg/mL (199.94 mM)Water:<1 mg/mL (<1 mM)
  Appearance:
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Haritunians T, et al. Oncol Rep. 2008, 20(5), 1237-1242.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting